NCT01628458View on ClinicalTrials.gov

Safety Study of Radiofrequency Ablation of Locally Advanced Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

November 30, 2014

Conditions
Locally Advanced Pancreatic Cancer
Interventions
PROCEDURE

radiofrequency ablation (RFA)

RFA with CELON bipolar probes. Settings: Power 30 watts, total energy 15 KJ.

Trial Locations (1)

3584 CX

University Medical Center Utrecht, Utrecht

All Listed Sponsors
lead

UMC Utrecht

OTHER

NCT01628458 - Safety Study of Radiofrequency Ablation of Locally Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter